PPM-3

N/A

Report date: 2023/10/08 09:43:31
NME

Base Information

Drug NamePPM-3
Drug Alias NamePPM-3
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionExtracellular-signal-regulated kinase 5 degraders
TargetsExtracellular-signal-regulated kinase 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPeking University School Of Pharmacy
China Registration ClassN/A

Develop Information

Active CompaniesPeking University School Of Pharmacy
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A